Borrelia + VlsE IgG CSF AI Control Set

Virotech Borrelia + VlsE IgG CSF AI Control Set (4 x 1 ml) - EN022L65

Paired controls for determining the accuracy and precision of the antibody index. To be used as additional tool with the corresponding enzyme-linked immunosorbent assays.

  • For quality control in daily CSF diagnostics laboratory routine
  • Ready-to-use, color coded reagents
  • CE-IVD

Disease: Lyme diseases

Symptoms: Multisystemic illness. Early manifestations: Erythema migrans; flu- like symptoms like fever, myalgias and headaches; carditis; meningitis. Late manifestations: Chronic neurological, dermatological and / or cardiological symptoms; Acrodermatitis chronica atrophicans; Herxheimer reaction; Lyme-Arthritis

Mechanism of Infection: Transmission by tick bite; Europe: Ixodes ricinus; USA: Ixodes dammini

EN022L65
Product
Order no.
Format
Wishlist
Borrelia + VlsE IgG CSF AI Control Set
Order no.EN022L65
Format4 x 1 ml
Add to wishlist

Documents

Name
Document type
Language
Format
Document
Borrelia + VlsE IgG CSF AI Control Set
IFUIFU
Language
Formatpdf
This document is only available for registered users. Login to reach it.
Borrelia + VlsE IgG CSF AI Control Set
BrochureBrochure
Language
English German
Formatpdf
Please select a language version!

RELATED PRODUCTS

Borrelia + VlsE IgG

Enzyme-linked immunosorbent assay intended as screening test for the semiquantitative and qualitative detection of IgG antibodies against Borrelia burgdorferi sensu lato in human serum or plasma.

Borrelia + VlsE IgG CSF Standards

CSF standards intended for drawing up a calibration curve used for the detection of CNS-own antibody synthesis by parallel examination of serum-CSF-pairs. To be used as additional tool with the corresponding enzyme-linked immunosorbent assays.

Borrelia + VlsE IgG Europe

Enzyme-linked immunosorbent assay intended as screening test for the semiquantitative and qualitative detection of IgG antibodies against Borrelia burgdorferi sensu lato in human serum or plasma.

Borrelia burgdorferi IgG

Enzyme-linked immunosorbent assay intended for the qualitative detection of IgG antibodies against Borrelia burgdorferi in human serum, plasma (citrate, heparin), and CSF (cerebrospinal fluid).

Borrelia burgdorferi IgM

Enzyme-linked immunosorbent assay intended for the qualitative detection of IgM antibodies against Borrelia burgdorferi in human serum, plasma (citrate, heparin), and CSF (cerebrospinal fluid).

Borrelia Europe + TpN17 IgG

Line Immunoblot for the qualitative detection of Borrelia burgdorferi sensu lato specific IgG antibodies in human serum.

Borrelia Europe IgG

Line Immunoblot for the qualitative detection of Borrelia burgdorferi sensu lato specific IgG antibodies in human serum.

Borrelia Europe IgM

Line Immunoblot for the qualitative detection of Borrelia burgdorferi sensu lato specific IgM antibodies in human serum.

Borrelia IgM

Enzyme-linked immunosorbent assay intended as screening test for the semiquantitative and qualitative detection of IgM antibodies against Borrelia burgdorferi sensu lato in human serum or plasma.

Borrelia IgM CSF Standards

CSF standards intended for drawing up a calibration curve used for the detection of CNS-own antibody synthesis by parallel examination of serum-CSF-pairs. To be used as additional tool with the corresponding enzyme-linked immunosorbent assays.

Borrelia in vivo + TpN17 IgG

Line Immunoblot for the qualitative detection of Borrelia burgdorferi sensu lato specific IgG antibodies in human serum.

Borrelia in vivo IgG

Line Immunoblot for the qualitative detection of Borrelia burgdorferi sensu lato specific IgG antibodies in human serum.

Borrelia in vivo IgM

Line Immunoblot for the qualitative detection of Borrelia burgdorferi sensu lato specific IgM antibodies in human serum.